EMA’s proposed Guideline on Quality and Equivalence of Topical Products and Nanotechnology: Future Advances and Challenges

Authors

  • Nathalie Hasler-Nguyen Labhnn, Crassier 7, 1260 Nyon, Switzerland

DOI:

https://doi.org/10.33892/aph.2021.91.232-233

Keywords:

In vitro drug release (IVRT), in vitro skin permeation (IVPT), generics, pharmacodynamic, nanotechnology, spectrocopy

Published

2021-11-15

How to Cite

(1)
Hasler-Nguyen, N. EMA’s Proposed Guideline on Quality and Equivalence of Topical Products and Nanotechnology: Future Advances and Challenges . Acta Pharm Hung 2021, 91, 232-233.

Issue

Vol. 91 No. 3-4 (2021): Abstracts of DDRS 2021 Conference, November 15-17, 2021, Budapest, Hungary

Section

Short communication

Copyright (c) 2021 Acta Pharmaceutica Hungarica

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

APH is published as a diamond open-access journal under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Creative Commons License